Nexus Company Profile

✉ Email this page to a colleague

NEXUS has twenty-three approved drugs.

There are five US patents protecting NEXUS drugs.

There are ten patent family members on NEXUS drugs in nine countries and eighty-eight supplementary protection certificates in nine countries.

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Nexus	POTASSIUM CHLORIDE 10MEQ	potassium chloride	INJECTABLE;INJECTION	214727-002	Mar 18, 2021	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
Nexus	STERILE WATER FOR INJECTION	sterile water for injection	LIQUID;N/A	217536-002	Jul 11, 2023	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
Nexus Pharms	FLUORESCEIN SODIUM	fluorescein sodium	INJECTABLE;INTRAVENOUS	215709-001	Sep 25, 2023	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
Nexus	PROCHLORPERAZINE EDISYLATE	prochlorperazine edisylate	INJECTABLE;INJECTION	204860-001	Feb 15, 2019	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
Nexus	TRANEXAMIC ACID	tranexamic acid	SOLUTION;INTRAVENOUS	216877-001	Apr 16, 2024	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
Nexus	EMERPHED	ephedrine sulfate	SOLUTION;INTRAVENOUS	213407-001	Apr 17, 2020		RX	Yes	Yes	11,478,436	⤷ Subscribe				⤷ Subscribe
Nexus	PROCAINAMIDE HYDROCHLORIDE	procainamide hydrochloride	INJECTABLE;INJECTION	206332-002	Oct 13, 2017	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Subscribe
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0290047	SPC/GB97/078	United Kingdom	⤷ Subscribe	PRODUCT NAME: MANGAFODIPIR AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN PARTICULAR MANGAFODIPIR TRISODIUM; REGISTERED: UK EU/1/97/040/001 19970522; UK EU/1/97/040/002 19970522
2203431	CA 2015 00014	Denmark	⤷ Subscribe	PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REG. NO/DATE: EU/1/14/983 20150115
1666481	17C1031	France	⤷ Subscribe	PRODUCT NAME: TOFACITINIB,EVENTUELLEMENT SOUS LA FORME D'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE,DONT LE CITRATE DE SODIUM; REGISTRATION NO/DATE: EU/1/17/1178 20170324
1758590	2017C/063	Belgium	⤷ Subscribe	PRODUCT NAME: SEL DE SODIUM D'ACIDE DESOXYCHOLIQUE; AUTHORISATION NUMBER AND DATE: SE/H/1547/01/DC 20170612
1259550	08C0052	France	⤷ Subscribe	PRODUCT NAME: SUGAMMADEX SODIUM; REGISTRATION NO/DATE: EU/1/08/466/001-002 20080725
2673237	1990016-6	Sweden	⤷ Subscribe	PRODUCT NAME: SODIUM ZIRCONIUM CYCLOSILICATE; REG. NO/DATE: EU/1/17/1173 20180326
2203431	CR 2015 00014	Denmark	⤷ Subscribe	PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REG. NO/DATE: EU/1/14/983 20150119
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.